DeepLife
DeepLife is a biotech company founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, dedicated to curing diseases at the cellular level using Digital Twins of cells. Their platform integrates multi-omics data, AI, and systems engineering to identify molecular triggers that can revert diseased cells to a healthy state. The company aims to reduce drug discovery timelines from years to months and improve the industry's success rate by providing a deeper understanding of disease mechanisms. DeepLife's technology accelerates the development of safe and effective therapies by simulating disease at the single-cell level, transforming drug development processes for biotech and pharmaceutical partners.
DeepLife
DeepLife is a biotech company founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, dedicated to curing diseases at the cellular level using Digital Twins of cells. Their platform integrates multi-omics data, AI, and systems engineering to identify molecular triggers that can revert diseased cells to a healthy state. The company aims to reduce drug discovery timelines from years to months and improve the industry's success rate by providing a deeper understanding of disease mechanisms. DeepLife's technology accelerates the development of safe and effective therapies by simulating disease at the single-cell level, transforming drug development processes for biotech and pharmaceutical partners.